Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2016, Article ID 2132056, 4 pages
http://dx.doi.org/10.1155/2016/2132056
Case Report

Fulminant Hepatic Failure in a Patient with Crohn’s Disease on Infliximab Possibly Related to Reactivation of Herpes Simplex Virus 2 Infection

1Department of Medicine, University of Saskatchewan, 103 Hospital Drive, Saskatoon, SK, Canada S7N 0W8
2Division of Gastroenterology, Department of Medicine, University of Saskatchewan, 103 Hospital Drive, Saskatoon, SK, Canada S7N 0W8

Received 14 July 2016; Accepted 19 September 2016

Academic Editor: Sandeep Mukherjee

Copyright © 2016 Gary Golds and Lawrence Worobetz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Norvell, A. T. Blei, B. D. Jovanovic, and J. Levitsky, “Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases,” Liver Transplantation, vol. 13, no. 10, pp. 1428–1434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. F. V. Schiødt, T. J. Davern, A. O. Shakil, B. McGuire, G. Samuel, and W. M. Lee, “Viral hepatitis-related acute liver failure,” American Journal of Gastroenterology, vol. 98, no. 2, pp. 448–453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Sharma and M. Mosunjac, “Herpes simplex hepatitis in adults: a search for muco-cutaneous clues,” Journal of Clinical Gastroenterology, vol. 38, no. 8, pp. 697–704, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Biancofiore, M. Bisà, L. M. Bindi et al., “Liver transplantation due to Herpes Simplex virus-related sepsis causing massive hepatic necrosis after thoracoscopic thymectomy,” Minerva Anestesiologica, vol. 73, no. 5, pp. 319–322, 2007. View at Google Scholar · View at Scopus
  5. G. Boivin, B. Malette, and N. Goyette, “Disseminated herpes simplex virus type 1 primary infection in a healthy individual,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 20, no. 4, pp. 122–125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Chaillon, N. Schnepf, M. Jonas et al., “Case report: benefits of quantitative polymerase chain reaction in the clinical management of herpes simplex virus 1 infection with prominent hepatitis and unusual secondary progression,” Journal of Medical Virology, vol. 84, no. 3, pp. 457–461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Czakó, M. Dobra, V. Terzin, L. Tiszlavicz, and T. Wittmann, “Sepsis and hepatitis together with herpes simplex esophagitis in an immunocompetent adult,” Digestive Endoscopy, vol. 25, no. 2, pp. 197–199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Czartoski, C. Liu, D. M. Koelle, S. Schmechel, A. Kalus, and A. Wald, “Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman,” Journal of Clinical Microbiology, vol. 44, no. 4, pp. 1584–1586, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Glas, S. Smola, T. Pfuhl et al., “Fatal multiorgan failure associated with disseminated herpes simplex virus-1 infection: a case report,” Case Reports in Critical Care, vol. 2012, Article ID 359360, 4 pages, 2012. View at Publisher · View at Google Scholar
  10. A. Peppercorn, L. Veit, C. Sigel, D. J. Weber, S. Jones, and B. A. Cairns, “Overwhelming disseminated herpes simplex virus type 2 infection in a patient with severe burn injury: case report and literature review,” Journal of Burn Care and Research, vol. 31, no. 3, pp. 492–498, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Wind, M. V. van Herwaarden, F. Sebens, and M. Gerding, “Severe hepatitis with coagulopathy due to HSV-1 in an immunocompetent man,” Netherlands Journal of Medicine, vol. 70, no. 5, pp. 227–229, 2012. View at Google Scholar · View at Scopus
  12. M. Montalbano, G. I. Slapak-Green, and G. W. Neff, “Fulminant hepatic failure from herpes simplex virus: post liver transplantation acyclovir therapy and literature review,” Transplantation Proceedings, vol. 37, no. 10, pp. 4393–4396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. D. Moomaw, P. Cornea, R. C. Rathbun, and K. A. Wendel, “Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster,” Expert Review of Anti-Infective Therapy, vol. 1, no. 2, pp. 283–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. K. Tyring, D. Baker, and W. Snowden, “Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir,” Journal of Infectious Diseases, vol. 186, supplement 1, pp. S40–S46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. U. Navaneethan, E. Lancaster, P. G. Venkatesh, J. Wang, and G. W. Neff, “Herpes simplex virus hepatitis-it's high time we consider empiric treatment,” Journal of Gastrointestinal and Liver Diseases, vol. 20, no. 1, pp. 93–96, 2011. View at Google Scholar · View at Scopus
  16. C. Riediger, P. Sauer, E. Matevossian, M. W. Müller, P. Büchler, and H. Friess, “Herpes simplex virus sepsis and acute liver failure,” Clinical Transplantation, vol. 23, supplement 21, pp. 37–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. G. P. Aithal, “Hepatotoxicity related to antirheumatic drugs,” Nature Reviews Rheumatology, vol. 7, no. 3, pp. 139–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Shelton, K. Chaudrey, J. Sauk et al., “New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease,” Alimentary Pharmacology and Therapeutics, vol. 41, no. 10, pp. 972–979, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Parisi, J. O’Beirne, R. E. Rossi et al., “Elevated liver enzymes in inflammatory bowel disease,” European Journal of Gastroenterology & Hepatology, vol. 28, no. 7, pp. 786–791, 2016. View at Publisher · View at Google Scholar
  20. F. Colina, A. Molero, B. Casís, and P. Martínez-Montiel, “Infliximab-related hepatitis: a case study and literature review,” Digestive Diseases and Sciences, vol. 58, no. 11, pp. 3362–3367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Murdaca, F. Spanò, M. Contatore et al., “Infection risk associated with anti-TNF-γ agents: a review,” Expert Opinion on Drug Safety, vol. 14, no. 4, pp. 571–582, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Atzeni, A. Batticciotto, I. F. Masala, R. Talotta, M. Benucci, and P. Sarzi-Puttini, “Infections and biological therapy in patients with rheumatic diseases,” The Israel Medical Association Journal, vol. 18, no. 3-4, pp. 164–167, 2016. View at Google Scholar
  23. A. M. G. Brunasso, M. Puntoni, A. Gulia, and C. Massone, “Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review,” Rheumatology, vol. 50, no. 9, pp. 1700–1711, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Viganò, G. Serra, G. Casella, G. Grossi, and P. Lampertico, “Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders,” Expert Opinion on Biological Therapy, vol. 16, no. 7, pp. 917–926, 2016. View at Publisher · View at Google Scholar
  25. H.-T. Tzeng, H.-F. Tsai, I.-T. Chyuan et al., “Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model,” PLoS ONE, vol. 9, no. 7, article e103008, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Chang, T. M. Block, and J.-T. Guo, “The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy,” Antiviral Research, vol. 96, no. 3, pp. 405–413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ellermann-Eriksen, “Macrophages and cytokines in the early defence against herpes simplex virus,” Virology Journal, vol. 2, p. 59, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Minagawa, K. Kashimoto, and Y. Yanagi, “Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections,” Journal of General Virology, vol. 85, no. 2, pp. 343–347, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Segan, M. P. Staples, L. March, M. Lassere, E. F. Chakravarty, and R. Buchbinder, “Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors,” Internal Medicine Journal, vol. 45, no. 3, pp. 310–318, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. E. A. Justice, S. Y. Khan, S. Logan, and P. Jobanputra, “Disseminated cutaneous herpes simplex virus-1 in a woman with rheumatoid arthritis receiving infliximab: a case report,” Journal of Medical Case Reports, vol. 2, article 282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. D. Bradford, A. C. Pettit, P. W. Wright et al., “Herpes simplex encephalitis during treatment with tumor necrosis factor-α inhibitors,” Clinical Infectious Diseases, vol. 49, no. 6, pp. 924–927, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Jansen, X. G. Vos, and M. Löwenberg, “Herpes simplex induced necrotizing tonsillitis in an immunocompromised patient with ulcerative colitis,” World Journal of Clinical Cases, vol. 4, no. 2, pp. 60–62, 2016. View at Publisher · View at Google Scholar
  33. R. M. Nanau, L. B. Cohen, and M. G. Neuman, “Risk of infections of biological therapies with accent on inflammatory bowel disease,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 17, no. 4, pp. 485–528, 2014. View at Publisher · View at Google Scholar · View at Scopus